FiercePharma
Register >>
April 8, 2025
1:00PM – 2:00PM EST
Traditional commercial strategies focus on known patient populations— but what about patients who aren’t on the radar?
AI-powered digital phenotyping and real-world data (RWD) offer new ways to locate overlooked patient populations, identify gaps between clinical guidelines and real-world treatment patterns, and optimize market positioning and messaging. Join OM1 experts in our upcoming webinar to learn how commercial teams can leverage AI-driven real-world insights and ensure their therapies reach the patients who need them most.
Speakers:
Joseph Zabinski, PhD, MEM
VP, Head of Commercial Strategy & AI
OM1
Kathryn Starzyk, ScM
Vice President of Real World Evidence at OM1
OM1